AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth

12 Jan 2026 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

05 Jan 2026 07:00:00 By Nasdaq GlobeNewswire

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

23 Dec 2025 19:45:00 By Nasdaq GlobeNewswire

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia

08 Dec 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

19 Nov 2025 09:45:14 By NetDania Notify

Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease

19 Nov 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

03 Nov 2025 09:01:00 By Nasdaq GlobeNewswire

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

30 Oct 2025 06:30:00 By Nasdaq GlobeNewswire

Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia

17 Oct 2025 08:00:54 By Nasdaq GlobeNewswire

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET

16 Oct 2025 07:00:00 By Nasdaq GlobeNewswire

Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia

04 Sep 2025 07:00:01 By Nasdaq GlobeNewswire

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

04 Aug 2025 16:01:00 By Nasdaq GlobeNewswire

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

31 Jul 2025 06:30:23 By Nasdaq GlobeNewswire

Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET

14 Jul 2025 07:00:00 By Nasdaq GlobeNewswire

Agios Appoints Dr. Jay Backstrom to Board of Directors

08 Jul 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025

28 May 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress

14 May 2025 10:00:00 By Nasdaq GlobeNewswire

Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025

09 May 2025 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

02 May 2025 07:00:00 By Nasdaq GlobeNewswire

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

01 May 2025 06:30:00 By Nasdaq GlobeNewswire